LY 2365109 hydrochloride is a chemical compound that belongs to a class of molecules known as selective serotonin reuptake inhibitors (SSRIs). It is primarily investigated for its potential therapeutic effects in treating various psychiatric disorders, particularly depression and anxiety. The compound exhibits a high affinity for serotonin receptors, which plays a crucial role in modulating mood and emotional responses. As a hydrochloride salt, it is typically more soluble in water, enhancing its bioavailability for pharmacological applications. The molecular structure of LY 2365109 includes specific functional groups that contribute to its pharmacodynamic properties, allowing it to interact effectively with neurotransmitter systems in the brain. Preclinical studies have suggested that it may offer a favorable side effect profile compared to other SSRIs, although comprehensive clinical data is necessary to fully establish its efficacy and safety. As with any investigational drug, ongoing research is essential to understand its mechanisms of action and potential therapeutic benefits.

LY 2365109 hydrochloride

868265-28-5: LY 2365109 hydrochloride is a chemical compound that belongs to a class of molecules known as selective serotonin reuptake inhibitors (SSRIs). It is primarily investigated for its potential therapeutic effects in treating various psychiatric disorders, particularly depression and anxiety. The compound exhibits a high affinity for serotonin receptors, which plays a crucial role in modulating mood and emotional responses. As a hydrochloride salt, it is typically more soluble in water, enhancing its bioavailability for pharmacological applications. The molecular structure of LY 2365109 includes specific functional groups that contribute to its pharmacodynamic properties, allowing it to interact effectively with neurotransmitter systems in the brain. Preclinical studies have suggested that it may offer a favorable side effect profile compared to other SSRIs, although comprehensive clinical data is necessary to fully establish its efficacy and safety. As with any investigational drug, ongoing research is essential to understand its mechanisms of action and potential therapeutic benefits.

<p>glycine transporter 1 (GlyT1) inhibitor</p>

CAS 868265-28-5

LY 2365109 hydrochloride

LY 2365109 hydrochloride

Ref: TM-T22945